Sat.Dec 30, 2023 - Fri.Jan 05, 2024

article thumbnail

Enhancement, Efficiency, Equity, and Engagement: Four Trends Shaping Clinical Trials in 2024

ACRP blog

Historically, patient recruitment and retention have been pressing issues within the clinical trial space. Eighty-five percent of trials fail to recruit enough patients, while 80% are delayed due to other factors like participant dropouts. These high rates are influenced by financial, emotional, and logistical barriers to participation, such as geographic location and travel-related costs, which prevent patients from enrolling in trials and accessing life-changing medicine.

article thumbnail

10 clinical trials to watch in the first half of 2024

Bio Pharma Dive

A non-addictive pain pill faces its definitive test, while study results in ALS, a rare heart disease and lung cancer could have far-reaching implications.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why amplifying the patient voice is crucial to clinical trial success

pharmaphorum

Amplifying the patient voice is essential for the success of clinical trials. Learn why it is crucial for patient engagement, recruitment, and overall trial success, and how it can address challenges such as transportation and financial barriers.

article thumbnail

Expert analysis: the latest in HIV research and clinical trials 

Pharmaceutical Technology

A new report from Novotech delves into the multifaceted landscape of HIV, focusing on its impact, treatment, and global initiatives.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Current Opportunities and Outcomes in Rare Disease Clinical Trials

WCG Clinical

This content is password protected. To view it please enter your password below: Password: The post Current Opportunities and Outcomes in Rare Disease Clinical Trials appeared first on WCG.

article thumbnail

Patients want access to clinical trials — here's how to give it to them

Antidote

While the primary goal of clinical trials is to help identify potential new treatments that improve people's health and save lives, it's the unfortunate truth that the patient experience is often not prioritized. This discrepancy becomes evident in industry findings, highlighting a substantial disparity between the services patients want from pharmaceutical companies compared to what they actually receive.

More Trending

article thumbnail

January 3, 2024: Special Biostatistics Series Concludes With Missing Data in Cluster Randomized Trials

Rethinking Clinical Trials

In this Friday's PCT Grand Rounds, Rui Wang of Harvard Medical School will offer the final session in our special series, Advances in the Design and Analysis of Pragmatic Clinical Trials, with "Methods for Handling Missing Data in Cluster Randomized Trials." The session will be held on Friday, January 5, at 1:00 pm eastern. Wang is an associate professor of population medicine and the director of the Division of Biostatistics in the Department of Population Medicine at Harvard Medical School and

Trials 298
article thumbnail

MRI Machines Are Perfectly Safe. But Never Do The Following Things.

AuroBlog - Aurous Healthcare Clinical Trials blog

A 57-year-old woman from Wisconsin recently sustained a rather unfortunate injury to her buttock. She had attended the hospital for an MRI ( magnetic resonance imaging) scan and had entered the machine with a concealed firearm. The machine’s powerful magnet caused the gun to discharge.

article thumbnail

Artificial intelligence in medical imaging revolutionizing diagnostics: Chandra Ganjoo

AuroBlog - Aurous Healthcare Clinical Trials blog

Medical imaging has revolutionized diagnostics with artificial intelligence (AI) providing the unprecedented accuracy for fast detection and personalized patient care. The year 2023 for India’s medtech industry characterized by resilience, innovation, provided push toward enhancing healthcare accessibility and quality amid global health challenges.

article thumbnail

A new startup from Feng Zhang and an ex-Illumina executive zeroes in on the epigenome

Bio Pharma Dive

Moonwalk Biosciences, the latest biotech cofounded by the gene editing scientist, joins other startups aiming to alter gene expression without changing DNA.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

AbbVie and Umoja to develop new CAR-T therapies for cancer

Pharmaceutical Technology

AbbVie and Umoja Biopharma partnered for the development of in-situ CAR-T cell therapy candidates for oncology targets.

article thumbnail

Risk model predicts response and survival of cancer patients treated with ICIs

Pharma Times

Metastatic cancer is estimated to be responsible for 90% of cancer deaths

153
153
article thumbnail

Shock Result Reveals The Fruit You May Want to Leave Out of Smoothies

AuroBlog - Aurous Healthcare Clinical Trials blog

The next time you make yourself a berry smoothie, you might want to hold off on the banana. Sure, this fruit is full of potassium and makes a drink deliciously thick and creamy, but according to researchers from the University of California Davis (UCD), there’s something in bananas that might overpower the antioxidants in berries.

Research 245
article thumbnail

Allogene to shift strategy in bid to reposition CAR-T

Bio Pharma Dive

The company plans to restructure and will start a new late-stage study testing whether its “off-the-shelf” therapy can boost cure rates when used early on.

323
323
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Novartis allies with Voyager to develop gene therapies in $1.3bn deal

Pharmaceutical Technology

Novartis will pay Voyager $100m upfront and up to $1.2bn in milestone-based payments and royalties on net sales.

article thumbnail

Millions of doses of Pfizer's Paxlovid will go to waste in UK, EU as COVID demand plummets

Fierce Pharma

On the heels of a major Paxlovid inventory write-off in the United States, many more doses of Pfizer's COVID-fighting antiviral are going to waste overseas. | At the end of November, more than 1.5 million courses of Pfizer’s Paxlovid had expired unused in European countries, analysts at Airfinity said in a new report. The total tally of expired doses in Europe is expected to hit 3.1 million by the end of next month, representing a value of $2.2 billion.

145
145
article thumbnail

Popular Type 2 Diabetes And Weight Loss Drug May Protect Against Colorectal Cancer

AuroBlog - Aurous Healthcare Clinical Trials blog

A drug commonly used to treat type 2 diabetes could also effectively protect against colorectal cancer (CRC), based on a new analysis by researchers in the US. The drug in question is a class of medications known as glucagon-like peptide-1 receptor agonists – more easily referred to as GLP-1 RAs.

Drugs 239
article thumbnail

5 FDA decisions to watch in the first quarter

Bio Pharma Dive

The agency could soon clear important new drugs from Eli Lilly and Merck, as well as the first treatment for a common liver disease.

Drugs 317
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Magazine: Pharma’s path to Net Zero: Targeting Scope 3 emissions

Pharmaceutical Technology

In this issue: Pharma’s efforts to curb Scope 3 emissions, understanding European Pharmaceutical legislation, and looking back at the pharma industry’s performance in 2023.

246
246
article thumbnail

Disrupted sleep could be associated with cognitive function changes

Pharma Times

High amounts of disrupted sleep were found to affect memory and thinking performance

141
141
article thumbnail

A Nutritionist Reveals The Secret to Making Friends With Salad

AuroBlog - Aurous Healthcare Clinical Trials blog

Do you hate salad? It’s OK if you do, there are plenty of foods in the world, and lots of different ways to prepare them.

article thumbnail

FDA ends busy year with three drug rejections

Bio Pharma Dive

Amgen had its bid for full approval of the cancer drug Lumakras turned back by the agency, which also issued complete response letters to Zealand Pharma and Merck & Co. in December.

Drugs 311
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Boehringer reinforces interest in NASH with new $2bn deal  

Pharmaceutical Technology

This collaboration comes six years after the German company Boehringer signed two agreements to develop treatments for NASH.

article thumbnail

JPM24, Day 2: BioNTech warns of COVID vaccine sales decline; Alnylam looks to become 'top-tier' biopharma player

Fierce Pharma

As the J.P. | As the J.P. Morgan Healthcare Conference rolled on in San Francisco, BioNTech, Alnylam and many other companies updated investors on their strategies heading into 2024.

Sales 138
article thumbnail

DDCDA devises strategies to differentiate their service with improved customer experience

AuroBlog - Aurous Healthcare Clinical Trials blog

Dharwad District Chemists & Druggists Association (DDCDA) is devising strategies to differentiate their service with improved customer experience. These span attention to details like patient education to manage their medication, ensure fair business practices in pricing and dispensing medicines efficiently among others.

Medicine 182
article thumbnail

An unusual drugmaker raises north of $100M for ecstasy-based PTSD therapy

Bio Pharma Dive

Lykos Therapeutics, formerly known as MAPS Public Benefit Corp., recently submitted its MDMA capsules for FDA approval, following two positive studies.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Pfizer receives Health Canada approval for haemophilia B therapy

Pharmaceutical Technology

Pfizer Canada has received Health Canada approval for gene therapy Beqvez (fidanacogene elaparvovec) for the treatment of haemophilia B.

article thumbnail

AnX Robotica receives FDA clearance for small bowel capsule endoscopy technology

Pharma Times

NaviCam ProScan is the first AI-assisted reading tool for gastrointestinal bleeding

Drugs 138
article thumbnail

Navigating regulatory affairs in biopharma industry requires skilled talent pool: Expert

AuroBlog - Aurous Healthcare Clinical Trials blog

Navigating regulatory affairs in the biopharma industry requires a skilled talent pool, according to Benjamin James, HR Leader, Asia-Pacific, Cytiva Lifesciences – a global life sciences (biopharma) company. He cited Cytiva’s Global Biopharma Resilience Index (GBRI), which reveals a decline in overall talent pool resilience, with the score dropping from 6.27 in 2021 to 5.

HR 168
article thumbnail

Lilly launches online service for home delivery of weight loss drug

Bio Pharma Dive

The new program, dubbed LillyDirect, will help patients connect with telehealth providers and deliver medicines like the company’s obesity treatment Zepbound.

Medicine 290
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.